← Eichor
Study identifier: NCT06691776 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Feasibility of CBCT-Guided Online Adaptive Radiotherapy (FASCINATE)

Condition: Prostate Cancer · Cervical Cancer · Bladder Cancer  ·  Sponsor: The Netherlands Cancer Institute

PhaseNA
Planned participants100
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The accuracy of radiotherapy can be increased by correcting for geometric uncertainties and changes between radiotherapy fractions. These corrections are currently done with online adaptive treatment on a specialized linear accelerator (linac) for a small subset of patients. However, patients currently treated on a standard linac could also benefit from online adaptive radiotherapy. The objective is to determine the feasibility of online CBCT-guided adaptive radiation therapy on a standard Elekta linac.

This description comes directly from the study's public registry record.

Talk to the study team

Evelien Schouten, MSc  ·  +31205129140  ·  ev.schouten@nki.nl

Always discuss trial participation with your own doctor first.

Locations (1)

Antoni van Leeuwenhoek HospitalAmsterdam, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06691776